{
    "nctId": "NCT03837496",
    "briefTitle": "Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors",
    "officialTitle": "Symptom-Targeted Randomized Intervention for Distress and Adherence to Adjuvant Endocrine Therapy (STRIDE) Among Breast Cancer Survivors: A Pilot Feasibility Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Adherence, Medication",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Feasibility and Acceptability",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Age 21 or older\n* Diagnosis of early-stage (Stage 0-IIIb), hormone receptor + breast cancer\n* Within 1 week-36 months of starting adjuvant endocrine therapy\n* Ability to read and respond in English\n* Eastern Cooperative Oncology Group (ECOG) performance status \u2264 2\n* Currently taking adjuvant endocrine therapy (i.e. if took recent break, has taken within the past 2 weeks)\n* Completed primary treatment (i.e., chemotherapy, surgery, and/or radiation) for early-stage breast cancer\n* Indicates a score \u22654 on one of the three NCCN adapted distress thermometer study screening questions\n\nExclusion Criteria:\n\n* Uncontrolled psychosis, active suicidal ideation, or psychiatric hospitalization within the past year\n* Cognitive impairment that prohibits participation in the study\n* Enrollment in a different clinical trial for breast cancer\n* Current participation in formal group psychotherapy or other psychosocial intervention trial\n* Undergoing primary treatment for other cancer (i.e., advanced stage cancer)",
    "sex": "FEMALE",
    "minimumAge": "21 Months",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}